Showing results (181-190 of 395) with videos related to

Sort By:
Pageof 40
Clinical and Experimental Immunology|June 1, 1984
Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the diseaseF Lauria, R Foa, M Cavo, et al.
Scandinavian Journal of Haematology|August 1, 1985
Non-Hodgkin's lymphomas in leukaemic phase: incidence, prognosis and therapeutic implicationsS Tura, P Mazza, F Lauria, et al.
Leukemia|May 1, 1997
Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitorsG Visani, D Russo, E Ottaviani, et al.
Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|November 1, 1989
S-phase evaluation with bromodeoxyuridine in lymphocytes from cattle infected with bovine leukemia virus (BLV)P L Tazzari, M Cipone, C Tassi, et al.
European Journal of Haematology|August 1, 1992
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA GroupL Gugliotta, M G Mazzucconi, G Leone, et al.
Haematologica|September 12, 2000
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patientsP L Zinzani, M Bendandi, V Stefoni, et al.
Acta Haematologica|January 1, 1979
Management of nodular sclerosis Hodgkin's disease stage I, II A and B: evidence for a beneficial effect of MOPP on the relapse rateF Lauria, M Baccarani, L Babini, et al.
British Journal of Haematology|October 1, 1983
E-rosette positive acute lymphoblastic leukaemia in adolescents and adultsM Baccarani, S Amadori, R Willemze, et al.
Haematologica|May 9, 1998
Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemiaE Zuffa, G Bandini, A Bonini, et al.
Acta Haematologica|January 1, 1996
Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patientsR M Lemoli, A Fortuna, M Fogli, et al.
Pageof 40